Latest Health News

Page 135 of 212
Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.
Ada Torres
Ada Torres
5 Aug 2025
Pinnacle Investment Management announces a fully franked dividend of AUD 0.27 per share for the half-year ending June 2025, offering shareholders a Dividend Reinvestment Plan with currency flexibility.
Claire Turing
Claire Turing
5 Aug 2025
Nutritional Growth Solutions has completed a $760,000 share placement at a slight discount, aiming to boost inventory and support its retail growth strategy.
Victor Sage
Victor Sage
5 Aug 2025
Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.
Ada Torres
Ada Torres
5 Aug 2025
Trajan Group Holdings has reported record FY25 revenue of $166.5 million, exceeding guidance despite operational headwinds. However, EBITDA fell slightly short of forecasts, reflecting challenges in supply chains and market shifts.
Ada Torres
Ada Torres
5 Aug 2025
HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.
Ada Torres
Ada Torres
5 Aug 2025
Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.
Ada Torres
Ada Torres
5 Aug 2025
Credit Corp Group Limited has announced a fully franked ordinary dividend of AUD 0.36 per share for the six months ending June 2025, signaling steady returns for investors.
Claire Turing
Claire Turing
5 Aug 2025
Hudson Investment Group faces intense scrutiny from ASX after its auditor issued a Disclaimer of Opinion on the 2024 financial report, citing doubts over a $2.4 million property receivable and the company’s going concern status.
Claire Turing
Claire Turing
4 Aug 2025
HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.
Ada Torres
Ada Torres
4 Aug 2025